Vinpocetine and Pyritinol: A New Model for Blood Rheological Modulation in Cerebrovascular Disorders—A Randomized Controlled Clinical Study

Table 1

Rheological properties of oral vinpocetine 10 mg/day for two weeks in cerebrovascular disorders.

Variables	Before	After	value
Hematocrit %	45.7 ± 0.23	44.2 ± 0.45
Total serum protein g/dl	8.64 ± 0.21	8.15 ± 1.76
Fibrinogen g/l	3.78 ± 0.87	2.01 ± 0.08
Relative blood viscosity cP	4.33 ± 0.65	2.11 ± 0.03
Actual blood viscosity cP	3.3685 ± 0.021	1.148 ± 0.032
WBV-HSR cP	6.6009 ± 0.032	6.337 ± 0.011
WBV-LSR cP	116.377 ± 0.165	97.935 ± 2.23
RRI	2.17 ± 0.011	1.17 ± 0.087
Plasma viscosity cP	1.55 ± 0.06	0.98 ± 0.08
Kinematic viscosity	3.18 ± 0.17	1.083 ± 0.64

WBV-HSR: whole blood viscosity high shear rate, WBV-LSR: whole blood viscosity low shear rate, and RRI: RBC rigidity index.